Skip to main content

Philips shares fall 8% after U.S. drug regulator deals fresh blow to sleep device recall

Shares of Dutch health tech company Philips fell on Friday after the U.S. drug regulator deemed its handling of a major product recall inadequate.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.